{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:46:13Z","timestamp":1761561973545,"version":"build-2065373602"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastrointestinal Endoscopy Clinics of North America"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.giec.2015.02.002","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T17:25:46Z","timestamp":1428773146000},"page":"449-462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Management of Antiplatelet Agents and Anticoagulants in Patients with Gastrointestinal Bleeding"],"prefix":"10.1016","volume":"25","author":[{"given":"Neena S.","family":"Abraham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.giec.2015.02.002_bib1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.amjcard.2009.10.014","article-title":"Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)","volume":"105","author":"Cannon","year":"2010","journal-title":"Am J Cardiol"},{"issue":"17","key":"10.1016\/j.giec.2015.02.002_bib2","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1161\/CIRCULATIONAHA.113.004747","article-title":"Risk of lower and upper gastrointestinal bleeding, transfusions, and hospitalizations with complex antithrombotic therapy in elderly patients","volume":"128","author":"Abraham","year":"2013","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.giec.2015.02.002_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/MOG.0000000000000122","article-title":"Gastrointestinal bleeding in cardiac patients: epidemiology and evolving clinical paradigms","volume":"30","author":"Abraham","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"issue":"20","key":"10.1016\/j.giec.2015.02.002_bib4","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archinternmed.2012.4026","article-title":"Use of new-generation oral anticoagulant agents in patients receiving antiplatelet therapy after an acute coronary syndrome: systematic review and meta-analysis of randomized controlled trials","volume":"172","author":"Komocsi","year":"2012","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.giec.2015.02.002_bib5","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1053\/j.gastro.2013.02.040","article-title":"Comorbidities affect risk of nonvariceal upper gastrointestinal bleeding","volume":"144","author":"Crooks","year":"2013","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.giec.2015.02.002_bib6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0016-5107(02)70402-1","article-title":"Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures","volume":"55","author":"Eisen","year":"2002","journal-title":"Gastrointest Endosc"},{"issue":"11","key":"10.1016\/j.giec.2015.02.002_bib7","first-page":"1079","article-title":"Antithrombotic therapy and invasive procedures","volume":"369","author":"Baron","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.giec.2015.02.002_bib8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.gie.2009.10.027","article-title":"A\u00a0lexicon for endoscopic adverse events: report of an ASGE workshop","volume":"71","author":"Cotton","year":"2010","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"10.1016\/j.giec.2015.02.002_bib9","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.gie.2009.09.040","article-title":"Management of antithrombotic agents for endoscopic procedures","volume":"70","author":"Anderson","year":"2009","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"10.1016\/j.giec.2015.02.002_bib10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/MOG.0b013e328365d415","article-title":"Novel anticoagulants: bleeding risk and management strategies","volume":"29","author":"Abraham","year":"2013","journal-title":"Curr Opin Gastroenterol"},{"issue":"12","key":"10.1016\/j.giec.2015.02.002_bib11","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1161\/CIRCRESAHA.114.302737","article-title":"Antiplatelet and anticoagulation therapy for acute coronary syndromes","volume":"114","author":"Bhatt","year":"2014","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.giec.2015.02.002_bib12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"issue":"9523","key":"10.1016\/j.giec.2015.02.002_bib13","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial","volume":"367","author":"Halkes","year":"2006","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.giec.2015.02.002_bib14","doi-asserted-by":"crossref","first-page":"e2852","DOI":"10.1371\/journal.pone.0002852","article-title":"A\u00a0randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility","volume":"3","author":"Sprigg","year":"2008","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.giec.2015.02.002_bib15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jacc.2012.06.004","volume":"60","author":"Jneid","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.giec.2015.02.002_bib16","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/jama.299.5.532","article-title":"Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome","volume":"299","author":"Ho","year":"2008","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.giec.2015.02.002_bib17","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.108.799403","article-title":"Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases","volume":"119","author":"van Werkum","year":"2009","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.giec.2015.02.002_bib18","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.108.813667","article-title":"Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents","volume":"119","author":"Eisenberg","year":"2009","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.giec.2015.02.002_bib19","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1038\/ajg.2009.667","article-title":"Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures","volume":"104","author":"Becker","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.giec.2015.02.002_bib20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/CIRCULATIONAHA.106.180944","volume":"115","author":"Grines","year":"2007","journal-title":"Circulation"},{"issue":"2 Suppl","key":"10.1016\/j.giec.2015.02.002_bib21","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.giec.2015.02.002_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/s-0030-1267856","article-title":"Review of currently available GP IIb\/IIIa inhibitors and their role in peripheral vascular interventions","volume":"27","author":"Stangl","year":"2010","journal-title":"Semin Intervent Radiol"},{"issue":"9302","key":"10.1016\/j.giec.2015.02.002_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(02)07442-1","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials","volume":"359","author":"Boersma","year":"2002","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.giec.2015.02.002_bib24","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jama.295.13.joc60034","article-title":"Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial","volume":"295","author":"Kastrati","year":"2006","journal-title":"JAMA"},{"issue":"6 Suppl","key":"10.1016\/j.giec.2015.02.002_bib25","doi-asserted-by":"crossref","first-page":"257S","DOI":"10.1378\/chest.08-0674","article-title":"Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Schulman","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.giec.2015.02.002_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1477-9560-6-15","article-title":"Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study","volume":"6","author":"Schulman","year":"2008","journal-title":"Thromb J"},{"issue":"4","key":"10.1016\/j.giec.2015.02.002_bib27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/gut.35.4.464","article-title":"Acute gastrointestinal haemorrhage in anticoagulated patients: diagnoses and response to endoscopic treatment","volume":"35","author":"Choudari","year":"1994","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.giec.2015.02.002_bib28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1572-0241.2006.00969.x","article-title":"Impact of anticoagulation on rebleeding following endoscopic therapy for nonvariceal upper gastrointestinal hemorrhage","volume":"102","author":"Wolf","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.giec.2015.02.002_bib29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cgh.2012.12.013","article-title":"Novel oral anticoagulants and gastrointestinal bleeding: a case for cardiogastroenterology","volume":"11","author":"Abraham","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.giec.2015.02.002_bib30","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.giec.2015.02.002_bib31","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1093\/eurheartj\/ehr113","article-title":"Dabigatran vs placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial","volume":"32","author":"Oldgren","year":"2011","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.giec.2015.02.002_bib32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1160\/TH10-07-0451","article-title":"Safety of edoxaban, an oral factor Xa inhibitor, in Asian patients with non-valvular atrial fibrillation","volume":"105","author":"Chung","year":"2011","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.giec.2015.02.002_bib33","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.giec.2015.02.002_bib34","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1161\/CIRCULATIONAHA.108.832139","article-title":"Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial","volume":"119","author":"APPRAISE Steering Committee and Investigators","year":"2009","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.giec.2015.02.002_bib35","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1105819","article-title":"Apixaban with antiplatelet therapy after acute coronary syndrome","volume":"365","author":"Alexander","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.giec.2015.02.002_bib36","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.giec.2015.02.002_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","author":"Mega","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.giec.2015.02.002_bib38","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1161\/CIR.0b013e318290826d","article-title":"Management of patients with atrial fibrillation (compilation of 2006 ACCF\/AHA\/ESC and 2011 ACCF\/AHA\/HRS recommendations): a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"Anderson","year":"2013","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.giec.2015.02.002_bib39","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.112.114967","article-title":"Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study","volume":"126","author":"Lamberts","year":"2012","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.giec.2015.02.002_bib40","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/CIRCULATIONAHA.111.090464","article-title":"Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial","volume":"126","author":"Healey","year":"2012","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.giec.2015.02.002_bib41","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1161\/CIRCULATIONAHA.112.123224","article-title":"Periprocedural management and approach to bleeding in patients taking dabigatran","volume":"126","author":"Weitz","year":"2012","journal-title":"Circulation"},{"issue":"10 Supplement","key":"10.1016\/j.giec.2015.02.002_bib42","doi-asserted-by":"crossref","first-page":"E316","DOI":"10.1016\/S0735-1097(13)60316-2","article-title":"Outcomes of temporary interruptions of rivaroxaban or warfarin in patients with atrial fibrillation in the ROCKET-AF trial","volume":"61","author":"Sherwood","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.giec.2015.02.002_bib43","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1160\/TH09-11-0758","article-title":"Dabigatran etexilate\u2013a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity","volume":"103","author":"van","year":"2010","journal-title":"Thromb Haemost"},{"issue":"21","key":"10.1016\/j.giec.2015.02.002_bib44","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1161\/CIRCULATIONAHA.113.002332","article-title":"Management and outcomes of major bleeding during treatment with dabigatran or warfarin","volume":"128","author":"Majeed","year":"2013","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.giec.2015.02.002_bib45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.beha.2013.07.001","article-title":"Bleeding and antidotes in new oral anticoagulants","volume":"26","author":"Majeed","year":"2013","journal-title":"Best Pract Res Clin Haematol"},{"issue":"Suppl","key":"10.1016\/j.giec.2015.02.002_bib46","article-title":"A\u00a0specific antidote for dabigatran: immediate, complete and sustained reversal of dabigatran induced anticoagulation in healthy male volunteers","volume":"128","author":"Glund","year":"2013","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.giec.2015.02.002_bib47","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1056\/NEJMc1411800","article-title":"Use of PER977 to reverse the anticoagulant effect of edoxaban","volume":"371","author":"Ansell","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.giec.2015.02.002_bib48","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/CIRCULATIONAHA.112.092833","article-title":"Periprocedural bridging management of anticoagulation","volume":"126","author":"Wysokinski","year":"2012","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.giec.2015.02.002_bib49","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1742-1241.2006.01081.x","article-title":"Low-molecular-weight heparin as bridging therapy during interruption of oral anticoagulation in patients undergoing colonoscopy or gastroscopy","volume":"61","author":"Constans","year":"2007","journal-title":"Int J Clin Pract"},{"issue":"10","key":"10.1016\/j.giec.2015.02.002_bib50","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1161\/CIR.0b013e318214876d","volume":"123","author":"Fuster","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.giec.2015.02.002_bib51","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jtcvs.2014.05.014","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"148","author":"Nishimura","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"13","key":"10.1016\/j.giec.2015.02.002_bib52","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.112.105221","article-title":"Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates","volume":"126","author":"Siegal","year":"2012","journal-title":"Circulation"},{"issue":"2 Suppl","key":"10.1016\/j.giec.2015.02.002_bib53","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.1378\/chest.11-2286","article-title":"Introduction to the ninth edition: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.giec.2015.02.002_bib54","doi-asserted-by":"crossref","first-page":"e496","DOI":"10.1161\/CIRCULATIONAHA.111.084517","article-title":"Bridging anticoagulation: is it needed when warfarin is interrupted around the time of a surgery or procedure?","volume":"125","author":"BRIDGE study investigators","year":"2012","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.giec.2015.02.002_bib55","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archinternmed.2012.4261","article-title":"Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding","volume":"172","author":"Witt","year":"2012","journal-title":"Arch Intern Med"}],"container-title":["Gastrointestinal Endoscopy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052515715000045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052515715000045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T07:18:50Z","timestamp":1760944730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052515715000045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1052515715000045"],"URL":"https:\/\/doi.org\/10.1016\/j.giec.2015.02.002","relation":{},"ISSN":["1052-5157"],"issn-type":[{"type":"print","value":"1052-5157"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Antiplatelet Agents and Anticoagulants in Patients with Gastrointestinal Bleeding","name":"articletitle","label":"Article Title"},{"value":"Gastrointestinal Endoscopy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.giec.2015.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}